Dapaveldactin 5 MG

Dapaveldactin 5 mg

Description:

Dapaveldactin 5 mg is an oral prescription antidiabetic medicine containing dapagliflozin, a selective sodium-glucose co-transporter 2 (SGLT2) inhibitor. It is used as part of comprehensive diabetes care to improve blood glucose control in adults with type 2 diabetes mellitus. By blocking SGLT2 in the kidneys, Dapaveldactin increases urinary glucose excretion, helping to lower blood sugar levels, reduce HbA1c, and support long-term diabetes management when combined with diet and exercise, and often with other antidiabetic medications such as metformin.

Indications:

• Type 2 diabetes mellitus in adults, as monotherapy when metformin is inappropriate due to intolerance or contraindication (e.g. renal impairment or gastrointestinal intolerance), as per physician judgment.
• Type 2 diabetes mellitus in adults as add-on therapy in combination with other glucose-lowering medicines (such as metformin, sulfonylureas, DPP-4 inhibitors, insulin) when these, together with diet and exercise, do not provide adequate glycemic control.
• Helps reduce elevated fasting and postprandial blood glucose levels.
• Contributes to reduction of HbA1c (glycated hemoglobin), improving long-term glycemic control.
• May aid in modest weight reduction and blood pressure lowering as part of overall metabolic control (effect varies between individuals).
• Used in diabetes care and health prevention strategies to lower the risk of long-term hyperglycemia-related complications when used as directed by a healthcare professional.

Active Ingredients / Key Components:

• Dapagliflozin – 5 mg per film-coated tablet.
• Other tablet excipients (film-coating agents, fillers, binders, etc.) are present but detailed composition is not available in the provided information.

Dosage & Administration / How to Use:

• Dapaveldactin 5 mg is for oral use only and should be taken exactly as prescribed by your physician.
• Typical adult dose: 5 mg once daily, swallowed whole with water. Your doctor may adjust the dose or combine it with other antidiabetic medicines based on your blood glucose response and overall health. Do not change your dose without medical advice.
• Can be taken with or without food, preferably at the same time each day to maintain consistent blood levels.
• Swallow the film-coated tablet whole; do not crush, break, or chew unless your pharmacist specifically advises otherwise.
• If you miss a dose, take it as soon as you remember on the same day. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not take a double dose to make up for a missed one.
• Continue following your prescribed diabetic diet, exercise plan, and regular blood glucose monitoring while using Dapaveldactin.
• Use with caution and under close medical supervision in patients with kidney impairment, elderly patients, or those taking diuretics due to increased risk of volume depletion.
• Do not use in type 1 diabetes or for the treatment of diabetic ketoacidosis.

Clinical Benefits:

• Improves glycemic control by lowering blood glucose levels through increased urinary glucose excretion.
• Helps reduce HbA1c, supporting long-term control of type 2 diabetes when combined with diet, exercise, and other prescribed therapies.
• Promotes heavy glycosuria (glucose loss in urine), which may contribute to modest weight reduction in some patients.
• May assist in lowering systolic blood pressure as part of overall cardiovascular risk management in type 2 diabetes (effect varies by patient and must be assessed by a physician).

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to dapagliflozin or any component of the formulation.
• Not indicated for type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis (DKA); may increase the risk of ketoacidosis, sometimes with only moderately elevated blood glucose.
• Use with caution in patients with moderate to severe renal impairment and in those with conditions that may predispose to volume depletion (e.g. low blood pressure, use of loop diuretics, elderly patients). Dose adjustment or discontinuation may be required based on renal function and clinical status.
• May increase risk of genital mycotic infections and urinary tract infections due to increased glucose in urine; patients should maintain good personal hygiene and seek medical advice if symptoms occur.
• Can cause volume depletion leading to dizziness, hypotension, or dehydration, especially in elderly patients or those on diuretics. Adequate fluid intake is recommended unless otherwise advised by your doctor.
• Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding; safety data in pregnancy and lactation are limited, and alternative therapies may be preferred.
• Inform your physician if you have a history of recurrent urinary tract infections, genital infections, low blood pressure, cardiovascular disease, kidney or liver disease.
• May affect kidney function; periodic monitoring of renal function (serum creatinine, eGFR) is recommended.
• In case of symptoms such as nausea, vomiting, abdominal pain, excessive thirst, difficulty breathing, confusion, or unusual fatigue, seek urgent medical attention as these may indicate ketoacidosis or severe dehydration.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision; must be used only under prescription and regular follow-up.
• Keep out of reach of children.

Side Effects:

• Common side effects may include increased urination, thirst, genital fungal infections (such as vulvovaginal candidiasis or balanitis), urinary tract infections, and mild reductions in blood pressure which may cause dizziness or lightheadedness.
• Less common side effects can include rash, pruritus, or hypersensitivity reactions. Discontinue and seek medical advice if signs of allergy (swelling of face, lips, tongue, or throat; severe rash; difficulty breathing) occur.
• Serious but rare side effects may include ketoacidosis (even with moderately elevated blood glucose), severe urinary tract infections (such as pyelonephritis or urosepsis), and significant volume depletion or acute kidney injury. Seek immediate medical attention if you experience severe abdominal pain, vomiting, rapid breathing, confusion, high fever, back or flank pain, or markedly reduced urine output.
• Report any unusual symptoms or persistent side effects to your doctor or pharmacist, especially if you have underlying kidney, liver, or cardiovascular disease.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Form: Film-coated tablets.
• Strength: 5 mg dapagliflozin per tablet.
• Pack size: 28 film-coated tablets per pack (28 f.c. tabs).
• Route of administration: Oral.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.